LENSAR (LNSR) Competitors

Embecta (NASDAQ:EMBC) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

Do institutionals and insiders believe in EMBC or LNSR?

93.8% of Embecta shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 0.4% of Embecta shares are held by insiders. Comparatively, 66.0% of LENSAR shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the media favor EMBC or LNSR?

In the previous week, Embecta had 3 more articles in the media than LENSAR. MarketBeat recorded 5 mentions for Embecta and 2 mentions for LENSAR. LENSAR's average media sentiment score of 1.86 beat Embecta's score of 1.19 indicating that LENSAR is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Embecta	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LENSAR	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has stronger earnings and valuation, EMBC or LNSR?

Embecta has higher revenue and earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.12B	0.50	$78.30M	$0.90	10.64
LENSAR	$53.49M	2.84	-$31.40M	-$4.85	-2.66

Which has more volatility & risk, EMBC or LNSR?

Embecta has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500.

Is EMBC or LNSR more profitable?

Embecta has a net margin of 4.89% compared to LENSAR's net margin of -99.17%. Embecta's return on equity of -19.67% beat LENSAR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Embecta	4.89%	-19.67%	12.27%
LENSAR	-99.17%	-737.30%	-81.69%

Do analysts rate EMBC or LNSR?

Embecta currently has a consensus price target of $19.33, indicating a potential upside of 101.81%. LENSAR has a consensus price target of $15.00, indicating a potential upside of 16.28%. Given Embecta's stronger consensus rating and higher possible upside, analysts clearly believe Embecta is more favorable than LENSAR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
LENSAR	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Embecta beats LENSAR on 13 of the 16 factors compared between the two stocks.